Clinical Trial Update: COVID-19: A Trial Studying the SARS-CoV-2 mRNA Vaccine CVnCoV to Learn About the Immune Response, the Safety, and the Degree of Typical Vaccination Reactions When CVnCoV is Given at the Same Time as a Flu Vaccine Compared to When the Vaccines Are Separately Given in Adults 60 Years of Age and Older [Phase 3]

View source ↗

Summary

Phase 3 trial investigating concurrent administration of the SARS-CoV-2 mRNA vaccine CVnCoV with a flu vaccine was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Disease 2019

Drugs mentioned

• CVnCoV (CVnCoV)

Snippet

Sponsor: Bayer | Conditions: SARS-CoV-2 Infection, Coronavirus Disease 2019 (COVID-19) | Phase 3 | Status: WITHDRAWN